J & J and Sientra get FDA warning letters over breast implants
The U.S. Food and Drug Administration has issued warning letters to Sientra Inc and a Johnson& Johnson unit for failing to comply with the post-approval study requirements for their breast implants.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Breast Augmentation | Food and Drug Administration (FDA) | Health | Plastic Surgery | Study | Warnings